1. Development and future directions of antiangiogenic therapy in hepatocellular carcinoma

   • Akinobu Taketomi

   Introduction to Invited Review Articles 20 February 2016 Pages: 205 - 205

2. Tumor angiogenesis—characteristics of tumor endothelial cells

   • Kyoko Hida
   • Nako Maishi
   • Yasuhiro Hida

   Invited Review Article 15 February 2016 Pages: 206 - 212

   

3. Clinical trials of antiangiogenic therapy for hepatocellular carcinoma

   • Akinobu Taketomi

   Invited Review Article 22 February 2016 Pages: 213 - 218

   

4. A population-based study on the associations between chronic periodontitis and the risk of cancer

   • Shiu-Dong Chung
   • Ming-Chieh Tsai
   • Chao-Hung Chen

   Original Article 18 August 2015 Pages: 219 - 223

5. Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy

   • Goshi Nishimura
   • Masanori Komatsu
   • Nobuhiko Oridate

   Original Article 14 August 2015 Pages: 224 - 230

   

6. Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer

   • Tommi T. Hakala
   • Juhani A. Sand
   • Pirkko-Liisa Kellokumpu-Lehtinen

   Original Article 26 September 2015 Pages: 231 - 239

   

7. Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer

   • Kyoichi Kaira
   • Noriaki Sunaga
   • Masanobu Yamada

   Original Article 13 August 2015 Pages: 240 - 247

   

8. Optimal strength and timing of steroids in the management of erlotinib-related skin toxicities in a post-marketing surveillance study (POLARSTAR) of 9909 non-small-cell lung cancer patients

   • Naoya Yamazaki
   • Yoshio Kiyohara
   • Masahiro Fukuoka

   Original Article Open access 26 October 2015 Pages: 248 - 253

   

9. Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers

   • Yukie Enomoto
   • Takashi Morimoto
   • Yasuo Miyoshi

   Original Article 04 September 2015 Pages: 254 - 261

   

10. Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes

    • Chiyomi Egawa
    • Kouichi Hirokaga
    • Yasuo Miyoshi

    Original Article 28 September 2015 Pages: 262 - 269

    

11. Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer

    • Hiroshi Nakagomi
    • Ikuko Sakamoto
    • Masao Omata

    Original Article 28 September 2015 Pages: 270 - 275

    

12. Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan

    • Keiichi Jingu
    • Rei Umezawa
    • Ken Takeda

    Original Article 01 September 2015 Pages: 276 - 282

    

13. Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial

    • Tomoya Yokota
    • Hiroyasu Igaki
    • Yuko Kitagawa

    Original Article 03 September 2015 Pages: 283 - 288

    

14. The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients

    • Toshiro Masuda
    • Masafumi Kuramoto
    • Hideo Baba

    Original Article 22 August 2015 Pages: 289 - 294

    

15. Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors

    • Tatsuo Kanda
    • Takashi Ishikawa
    • Seiichi Hirota

    Original Article 19 September 2015 Pages: 295 - 301

    

16. Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis

    • Kouji Kimura
    • Masaru Nakayama
    • Yoshifumi Ninomiya

    Original Article 21 August 2015 Pages: 302 - 309

    

17. Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy

    • Takaaki Higashi
    • Hiromitsu Hayashi
    • Hideo Baba

    Original Article 04 September 2015 Pages: 310 - 319

    

18. Current status of local treatment for early rectal cancer in Japan: a questionnaire survey by the 81st Congress of the Japanese Society for Cancer of the Colon and Rectum (JSCCR) in 2014

    • Hidetoshi Katsuno
    • Koutarou Maeda
    • Kenichi Sugihara

    Original Article 13 August 2015 Pages: 320 - 328

    

19. Growth rate of chemotherapy-naïve lung metastasis from colorectal cancer could be a predictor of early relapse after lung resection

    • Koji Kawaguchi
    • Keisuke Uehara
    • Kohei Yokoi

    Original Article 18 August 2015 Pages: 329 - 334

    

20. A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902)

    • Yutaka Ogata
    • Mototsugu Shimokawa
    • Kyushu Study Group of Clinical Cancer (KSCC)

    Original Article Open access 04 September 2015 Pages: 335 - 343

    

21. Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer

    • Ayako Tomono
    • Kimihiro Yamashita
    • Yoshihiro Kakeji

    Original Article 04 September 2015 Pages: 344 - 349

    

22. Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy

    • Susumu Saigusa
    • Yuji Toiyama
    • Masato Kusunoki

    Original Article 14 September 2015 Pages: 350 - 358

    

23. Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients

    • Tetsushi Tsuruga
    • Asaha Fujimoto
    • Tomoyuki Fujii

    Original Article 05 October 2015 Pages: 359 - 366

    

24. R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy

    • Akira Nagahara
    • Motohide Uemura
    • Norio Nonomura

    Original Article Open access 29 July 2015 Pages: 367 - 372

    

25. Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy

    • Gui-Ming Zhang
    • Yao Zhu
    • Ding-Wei Ye

    Original Article 03 September 2015 Pages: 373 - 378

    

26. Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy

    • Takuya Koie
    • Chikara Ohyama
    • Kazuyoshi Hirota

    Original Article 30 July 2015 Pages: 379 - 383

    

27. The processus vaginalis transection method is superior to the simple prophylactic procedure for prevention of inguinal hernia after radical prostatectomy

    • Toshihiro Kanda
    • Syohei Fukuda
    • Yukio Kageyama

    Original Article 06 August 2015 Pages: 384 - 388

    

28. Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up

    • Ryo Oka
    • Takanobu Utsumi
    • Hiroyoshi Suzuki

    Original Article 22 August 2015 Pages: 389 - 396

    

29. Is scintigraphy necessary to detect migration of ¹²⁵I seeds after brachytherapy for early prostate cancer?

    • Yu Odagaki
    • Makoto Ohori
    • Masaaki Tachibana

    Original Article 22 September 2015 Pages: 397 - 401

    

30. Relationship between quality of life instruments and phonatory function in tracheoesophageal speech with voice prosthesis

    • Masayuki Miyoshi
    • Takahiro Fukuhara
    • Hiroshi Hagino

    Original Article 13 August 2015 Pages: 402 - 408

31. Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy

    • Hirotoshi Iihara
    • Hironori Fujii
    • Yoshinori Itoh

    Original Article Open access 16 October 2015 Pages: 409 - 418